Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Özlem Satirer

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|December 10, 2025
[Autoinflammatory syndromes]Özlem Satirer, Eugen Feist, Yilmaz Satirer, et al.
Klinische Padiatrie|March 29, 2023
Miliary Pulmonary Nodules in a 9-Year-Old Child - The Search for the Origin and its Consequence for TreatmentÖzlem Satirer, Lars Daniel Berthold, Gabriele A Krombach, et al.
Journal of Clinical Medicine|January 28, 2026
Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile DermatomyositisOana Buzoianu, Özlem Satirer, Jasmin B Kuemmerle-Deschner, et al.
Journal of Clinical Medicine|December 11, 2025
Fatigue in Inactive Auto-Inflammatory Diseases and Opportunities for Optimizing Clinical Care: A Single-Center Observational StudyYilmaz Satirer, Özlem Satirer, Susanne M Benseler, et al.
Rheumatology (Oxford, England)|May 24, 2025
Pregnancy outcomes after maternal and paternal anti-IL-1 treatment exposure in cryopyrin-associated periodic syndromes (CAPS)Özlem Satirer, Jörg Henes, Melanie Henes, et al.
Rheumatology (Oxford, England)|July 6, 2024
Refining treat-to-target strategies in cryopyrin-associated periodic syndromes: the role of inflammatory markersÖzlem Satirer, Tatjana Welzel, Beate Zapf, et al.
RMD Open|July 14, 2024
Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in childrenÖzlem Satirer, Joerg C Henes, Michaela Döring, et al.
Rheumatology (Oxford, England)|August 1, 2025
Sensorineural hearing loss in anti-Interleukin-1 treated cryopyrin-associated periodic syndromes patients: risk factors and real-life barriers-an observational studyÖzlem Satirer, Anke Tropitzsch, Assen Koitschev, et al.
Journal of Clinical Medicine|April 27, 2024
Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment AdjustmentsTatjana Welzel, Beate Zapf, Jens Klotsche, et al.
Pediatric Rheumatology Online Journal|April 11, 2026
Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond bordersYagmur Bayindir, Özlem Satirer, Veysel Cam, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|December 10, 2025
[Autoinflammatory syndromes]Özlem Satirer, Eugen Feist, Yilmaz Satirer, et al.
Klinische Padiatrie|March 29, 2023
Miliary Pulmonary Nodules in a 9-Year-Old Child - The Search for the Origin and its Consequence for TreatmentÖzlem Satirer, Lars Daniel Berthold, Gabriele A Krombach, et al.
Journal of Clinical Medicine|January 28, 2026
Towards New Strategies: Case Report and Review of the Literature-Effective Use of JAK Inhibitor Baricitinib in a 4-Year-Old Boy with Anti-MDA5 Antibody-Positive Juvenile DermatomyositisOana Buzoianu, Özlem Satirer, Jasmin B Kuemmerle-Deschner, et al.
Journal of Clinical Medicine|December 11, 2025
Fatigue in Inactive Auto-Inflammatory Diseases and Opportunities for Optimizing Clinical Care: A Single-Center Observational StudyYilmaz Satirer, Özlem Satirer, Susanne M Benseler, et al.
Rheumatology (Oxford, England)|May 24, 2025
Pregnancy outcomes after maternal and paternal anti-IL-1 treatment exposure in cryopyrin-associated periodic syndromes (CAPS)Özlem Satirer, Jörg Henes, Melanie Henes, et al.
Rheumatology (Oxford, England)|July 6, 2024
Refining treat-to-target strategies in cryopyrin-associated periodic syndromes: the role of inflammatory markersÖzlem Satirer, Tatjana Welzel, Beate Zapf, et al.
RMD Open|July 14, 2024
Autologous haematopoiesis stem cell transplantation (AHSCT) for treatment-refractory autoimmune diseases in childrenÖzlem Satirer, Joerg C Henes, Michaela Döring, et al.
Rheumatology (Oxford, England)|August 1, 2025
Sensorineural hearing loss in anti-Interleukin-1 treated cryopyrin-associated periodic syndromes patients: risk factors and real-life barriers-an observational studyÖzlem Satirer, Anke Tropitzsch, Assen Koitschev, et al.
Journal of Clinical Medicine|April 27, 2024
Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment AdjustmentsTatjana Welzel, Beate Zapf, Jens Klotsche, et al.
Pediatric Rheumatology Online Journal|April 11, 2026
Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond bordersYagmur Bayindir, Özlem Satirer, Veysel Cam, et al.
Pageof 2